RCM

RA Capital Management Portfolio holdings

AUM $9.76B
1-Year Est. Return 103.63%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+103.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.76B
AUM Growth
+$1.65B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
88
New
Increased
Reduced
Closed

Top Buys

1 +$114M
2 +$105M
3 +$72M
4
PRAX icon
Praxis Precision Medicines
PRAX
+$69.6M
5
EVMN
Evommune Inc
EVMN
+$65M

Top Sells

1 +$292M
2 +$141M
3 +$55.5M
4
BLTE
Belite Bio
BLTE
+$52.4M
5
DNTH icon
Dianthus Therapeutics
DNTH
+$48.7M

Sector Composition

1 Healthcare 99.82%
2 Financials 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OVID icon
51
Ovid Therapeutics
OVID
$116M
$17.5M 0.18%
+10,714,000
PALI icon
52
Palisade Bio
PALI
$264M
$16.7M 0.17%
+7,124,116
SABS icon
53
SAB Biotherapeutics
SABS
$195M
$16.5M 0.17%
4,401,500
CCCC icon
54
C4 Therapeutics
CCCC
$262M
$15.3M 0.16%
+8,000,000
MDLN
55
Medline Inc
MDLN
$38.6B
$14.1M 0.14%
+335,000
DSGN icon
56
Design Therapeutics
DSGN
$595M
$13.7M 0.14%
1,461,381
+985,682
INSP icon
57
Inspire Medical Systems
INSP
$1.84B
$13.1M 0.13%
141,964
+27,063
AVTX icon
58
Avalo Therapeutics
AVTX
$324M
$12M 0.12%
662,968
RANI icon
59
Rani Therapeutics
RANI
$134M
$11.5M 0.12%
+8,500,000
PCSC
60
Perceptive Capital Solutions
PCSC
$141M
$9.77M 0.1%
750,000
ACET icon
61
Adicet Bio
ACET
$69.6M
$7.98M 0.08%
948,249
+476,936
NAMSW icon
62
NewAmsterdam Pharma Warrant
NAMSW
$7.67M 0.08%
333,333
WGS icon
63
GeneDx Holdings
WGS
$2.3B
$7.55M 0.08%
58,044
WAY
64
Waystar Holding Corp
WAY
$4.92B
$4.73M 0.05%
+144,400
HOWL icon
65
Werewolf Therapeutics
HOWL
$29.1M
$4.23M 0.04%
6,681,307
HNGE
66
Hinge Health
HNGE
$3.37B
$3.72M 0.04%
+80,113
PGNY icon
67
Progyny
PGNY
$1.53B
$2.48M 0.03%
96,628
QGEN icon
68
Qiagen
QGEN
$10.3B
$2.08M 0.02%
+43,976
KIDS icon
69
OrthoPediatrics
KIDS
$481M
$1.95M 0.02%
+109,959
HCAT icon
70
Health Catalyst
HCAT
$115M
$1.9M 0.02%
+793,749
PTN
71
Palatin Technologies
PTN
$35.6M
$1.08M 0.01%
+70,000
CTMX icon
72
CytomX Therapeutics
CTMX
$910M
-2,661,331
ELDN icon
73
Eledon Pharmaceuticals
ELDN
$209M
-3,566,338
ETNB
74
DELISTED
89bio
ETNB
-19,889,683
EVH icon
75
Evolent Health
EVH
$363M
-579,052